DAY 1 Friday, September 2nd, 2022 |
||||
---|---|---|---|---|
Time (EET) in hrs | Theme | Moderator | Speaker | Talk title |
08:45 – 09:15 | REGISTRATION | |||
09:15 – 09:30 | OPENING OF THE CONFERENCE | Welcome by Toomas Asser, Rector, University of Tartu, Estonia | ||
09:30 – 11:30 | Personalized medicine in psychiatry | Lili Milani and Kelli Lehto | Brenda Penninx Amsterdam UMC Netherlands |
Using genetics to unravel the heterogeneity of depression |
Henrik Larsson Örebro University Sweden |
Psychiatric epidemiology using national register data: Challenges and opportunities | |||
Christiane Gasse Ahrus University Denmark |
From associations to clinical utility: impact of functional CYP2C19 and CYP2D6 gene variants on treatment in patients with depression: a Danish cohort study | |||
Lu Yi Karolinska Institute Sweden |
A multidisciplinary approach to better understand treatment resistant depression | |||
11:30 – 12:30 | LUNCH BREAK | |||
12:30 – 14:00 | A tour at the Estonian National Museum | |||
14:00 – 16:00 | Immunology and Epigenetics | Pärt Peterson and Ana Rebane | Dario Greco University of Tampere Finland |
Integrated approaches to chemical safety assessment and drug design |
Ulf Andersson Vang Orom Aarhus University Denmark |
m6A RNA modifications, splicing and cancer | |||
Benjamin Fairfax University of Oxford United Kingdom |
Exploring the interplay between germline genetic variation and responses to cancer immunotherapy and chronic viral infection across a large patient cohort | |||
Anne Puel French Institute of Health and Medical Research France |
Autoimmune phenocopies of inborn errors of immunity underlying infectious diseases | |||
16:00 – 16:30 | COFFEE BREAK | |||
16:30 – 18:30 | Genetic and phenotypic variance | Kaur Alasoo | Ewan Birney EMBL-EBI United Kingdom |
Big data in biology: what the pandemic has taught us |
Claudia Langenberg University of Cambridge/ Berlin Institute of Health at Charité United Kingdom/Germany |
From molecules to health records: utility of omics at population scale | |||
Dietmar Frey CLAIM – the Charité Lab for AI in Medicine Germany |
The Challenge of Translational Research | |||
Elo Madisson Wellcome Sanger Institute United Kingdom |
A spatial multi-omics atlas of the human lung reveals a novel gland-associated immune niche | |||
19:00 – 00:00 | DINNER at Estonian National Museum |
DAY 2 Saturday, September 3rd, 2022 |
||||
---|---|---|---|---|
Time (EET) in hrs | Theme | Moderator | Speaker | Talk title |
09:30 – 10:30 | Immunology and Epigenetics | Kaur Alasoo | Michael Simpson Kings College London United Kingdom |
Driving discovery in inflammatory skin disease with human genetics |
Presentation by Illumina | Tiffany Morris
Kalina Cetnar |
Illumina toolkit for PGx and PRS | ||
10:30 – 11:00 | COFFEE BREAK | |||
11:00 – 12:30 | Parkinson Disease | Andres Metspalu | Mart Saarma University of Helsinki Finland |
Search for new molecules to cure Parkinson’s disease |
Alastair Noyce Queen Mary University of London United Kingdom |
Determinants of Parkinson’s disease – genes, environment and interactions | |||
Toomas Toomsoo Confido Medical Center Estonia |
Polygenic risk score for Parkinson’s disease and probability of substantia nigra hyperechogenicity in “healthy” adults | |||
12:30 – 14:00 | LUNCH BREAK | |||
14:00 – 17:00 | Microbiome and population genomics | Mait Metspalu and Elin Org | Paul Wilmes University of Luxembourg Luxembourg |
Systems Ecology of Human-Microbiome Interactions in Health and Disease |
Leo Lahti Univerity of Turku Finland |
Emerging computational approaches in population studies of the human microbiome | |||
Adrian Tett University of Vienna Austria |
The impact of Westernization on the human gut microbiome | |||
15:30 – 16:00 | COFFEE BREAK | |||
Microbiome and population genomics(continued…) | Mait Metspalu and Elin Org | Hannes Schroeder University of Copenhagen Denmark |
Challenges and prospects in ancient metagenomcis | |
Jon Anders Eriksson University of Tartu Estonia |
The influence of population admixtures on the evolution of complex human traits: insights from genomic, phenotypic and functional data |
|||
17:00 – 17:15 | CLOSING REMARKS |